Nateglinide quantification in rabbit plasma by HPLC: Optimization and application to pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 1, 2007, Pages 196-204

  Sankalia, Jolly M ^a   Sankalia, Mayur G ^a   Sutariya, Vijay B ^a   Mashru, Rajashree C ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

HPLC; Nateglinide; Optimization; Pharmacokinetic; Plasma

Indexed keywords

ACETONITRILE; GLICLAZIDE; METHANOL; NATEGLINIDE; PHOSPHATE BUFFERED SALINE;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; MULTIPLE CYCLE TREATMENT; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PRIORITY JOURNAL; RABBIT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SUSTAINED RELEASE PREPARATION; ULTRAVIOLET RADIATION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BUFFERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLD; CYCLOHEXANES; DRUG STABILITY; FREEZING; HALF-LIFE; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; METABOLIC CLEARANCE RATE; MOLECULAR STRUCTURE; PHENYLALANINE; RABBITS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 34047244717     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.02.028     Document Type: Article

References (25)

1. Fujitani S., Okazaki K., and Yada T. J. Pharmacol. 120 (1997) 1191-1198
2. Karara A.H., Dunning B.E., and McLeod J.F. J. Clin. Pharmacol. 39 (1999) 172-179
3. In: Harmel A.P., and Mathur R. (Eds). In Davidson's Diabetes Mellitus-Diagnosis and Treatment. fifth ed. (2004), Saunders-An Imprint of Elsevier, Philadelphia, Pennsylvania pp. 71-108
4. Ono I., Matsuda K., and Kanno S. J. Chromatogr. B Biomed. Appl. 678 (1996) 384-387
5. Ono I., Matsuda K., and Kanno S. J. Chromatogr. B Biomed. Sci. Appl. 692 (1997) 397-404
6. Ho E.N.M., Yiu K.C.H., Wan T.S.M., Stewart B.D., and Watkins K.L. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 811 (2004) 65-73
7. Yan H., Yang G., Qiao F., and Chen Y. J. Pharm. Biomed. Anal. 36 (2004) 169-174
8. Yin J., Yang G., and Chen Y. J. Chromatogr. A 1090 (2005) 68-75
9. Koseki N., Kawashita H., Niina M., Nagae Y., and Masuda N. J. Pharm. Biomed. Anal. 36 (2005) 1063-1072
10. Bauer S., Störmer E., Julia K., Michael C., Brockmöller J., and Roots I. J. Pharm. Biomed. Anal. 31 (2003) 551-555
11. Kanji M., and Shigeya T. Anal. Sci. 14 (1998) 361-368
12. Sáiz-Abajo M.J., González-Sáiz J.M., and Consuelo P. Anal. Chim. Acta 528 (2005) 63-76
13. ICH Guidelines: Validation of Analytical Procedures: Q2B, 1996.
14. ICH Guidelines: Validation of Analytical Procedures: Q2A, 1994.
15. Guidance for the Industry: Analytical Method Validation, US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD, 2000.
16. Hubert P.H., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. Anal. Chim. Acta 391 (1999) 135-148
17. Hubert P.H., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., and Nivet J.C. S.T.P. Pharma Practise 13 (2003)
18. Currie L.A. Pure Appl. Chem. 67 (1995) 1699-1723
19. I.S. 8466-2, in: Water quality-Calibration and evaluation of analytical methods and estimation of performance characteristics, 1994.
20. Milena G., Ramirez G., Velasquez O., Perez M., and Restrepo P. ARS Pharma. 46 (2005) 411-427
21. In: Sethi P.D. (Ed). High Performance Liqid Chromatography-Quantitative Analysis of Pharmaceutical Formulations. first ed. (2001), CBS Publishers & Distributors, Mumbai pp. 3-212
22. Ban K., and Kiyokatsu J. Anal. Sci. 17 (2001) 113-117
23. Guidance for the Industry: Bioanalytical Method Validation (http://www.fda.gov/cder/guidance/4252fnl.pdf), Department of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD, 2001.
24. Meyyanathan S.N., Ramasarma G.V.S., and Suresh B. ARS Pharma. 45 (2004) 121-129
25. http://www.fda.gov/cder/foi/nda/2000/21-204_Stsrlix.htm, http://.../21-204_Stsrlix_pharmr_P1.pdf, http://.../21-204_Stsrlix_pharmr_P2.pdf, last accessed on July 13, 2006, CDER Freedom of Information, 2000.